AC Immune S.A. (ACIU) Financials

ACIU Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 171.6 million 132.2 million
Dec. 31, 2025 194.6 million 138.0 million
Sept. 30, 2025 215.5 million 137.1 million
June 30, 2025 239.9 million 145.7 million

ACIU Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 ? ?
Dec. 31, 2025 -20.9 million 1.1 million
Sept. 30, 2025 -23.1 million 1.0 million
June 30, 2025 -20.1 million 467926

ACIU Net Income

No data available :(

ACIU Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 - - 5.4 million
Dec. 31, 2025 115.3 million - 4.7 million
Sept. 30, 2025 136.2 million - 5.9 million
June 30, 2025 160.3 million - 6.2 million

ACIU Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 127.1 million
Dec. 31, 2025 127.5 million
Sept. 30, 2025 124.4 million
June 30, 2025 126.9 million

ACIU Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 - 14.7 million 5.2 million -
Dec. 31, 2025 135065 13.3 million -320137 -
Sept. 30, 2025 72827 16.4 million 4.5 million -
June 30, 2025 470448 21.2 million 4.9 million -

ACIU Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 1.4 million -
Dec. 31, 2025 426009 -
Sept. 30, 2025 1.2 million -
June 30, 2025 1.6 million -

ACIU

Price: $2.31

52 week price:
1.63
4.00

Earnings Per Share: -0.84 USD

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Country: Switzerland

Volume: 182100

Ebitda: -8.8 million

Market Capitalization: 239.7 million

Links: